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ABSTRACT
Mitochondrial NEET proteins are recently discovered iron-sulfur proteins that are
localized within mitochondria. There are three NEET proteins: mitoNEET, a type II diabetes
drug pioglitazone binding target, a mitoNEET related protein 1 (Miner1 or NAF-1), and a
mitoNEET-related protein 2 (Miner2). While both mitoNEET and Miner1 are mitochondrial
outer membrane proteins, Miner2 is a mitochondrial matrix protein. All three NEET proteins
bind at least one [2Fe-2S] cluster via CDGSH (Cys-Asp-Gly-Ser-His) motif. In this work, we
have investigated the electron transfer activity of mitoNEET, and found that the CDGSH-type
[2Fe-2S] clusters of mitoNEET can be reduced by the reduced flavin mononucleotide (FMNH2)
under anaerobic or aerobic conditions in vitro. We have also found that the reduced mitoNEET
[2Fe-2S] clusters can be oxidized by ubiquinone or oxygen. Further studies have demonstrated
that the type II diabetes medication pioglitazone may compete for the FMNH2 binding site of
mitoNEET, and inhibit the reduction of the mitoNEET [2Fe-2S] clusters by FMNH2. We have
also described the inhibitory effect of nitric oxide on the electron transfer activity of the
mitochondrial matric protein Miner2. We have found that nitric oxide can bind to the reduced
Miner2 [2Fe-2S] clusters without disruption of the cluster, and that visible light excitation can
quickly release nitric oxide from the nitric oxide-bound cluster in Miner2. Binding of nitric oxide
effectively inhibits the electron transfer activity of the Miner2 [2Fe-2S] clusters. The results
suggest that mitochondrial NEET-proteins may play a novel role in energy metabolism in cells,
and that nitric oxide may regulate the electron transfer activity of the NEET-proteins and
modulate the energy metabolism in mitochondria via directly binding to the [2Fe-2S] clusters in
the proteins.
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CHAPTER 1. INTRODUCTION
1.1 Iron-sulfur Clusters
Iron-sulfur clusters (ISC) are one of the most ancient and conservative cofactors (1).
More than 500 distinct proteins with versatile forms of ISC have been found in achaea, bacteria,
and eukaryotes, since ferredoxin, the first known ISC containing protein, was found in 1960s (23).
There are various numbers of Fe and S atoms in different forms of ISC. The most
common forms of ISC are the [2Fe-2S] clusters and the [4Fe-4S] clusters (Figure 1.1) (4). The
[2Fe-2S] and [4Fe-4S] are generally ligated to proteins through cysteine residue. In some cases,
aspartate, histidine, or serine can also be the ligands for the iron-sulfur clusters in proteins (5).
The primary biological function of the ISC is electron transfer, as the Fe in ISC can be
both electron acceptor and donor (6). For example, a chain of ISC in the complex I of
mitochondria transfer electrons from NADH in matrix to the ubiquinone embedded in the
mitochondrial inner membrane (7). The second role of ISC is to serve as the active center in an
enzyme. For example, fumarase A from Escherichia coli, catalyzes the reversible
hydration/dehydration of fumarate holds a [4Fe-4S] in its active center (8). The third function of
ISC is the regulation of gene expression. The examples are bacterial transcription factors SoxR,
FNR, IRP, IscR (9-11).
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Figure 1.1 Structures, core oxidation states, and spin states of crystallographically defined [Fe-S]
clusters.
Iron is shown in red, and sulfur is shown in yellow. The spin state, denoted by a question mark,
has yet to be determined. The [3Fe-4S] cluster has only been observed as a fragment in
heterometallic [M-3Fe-4S]+ clusters (not shown) in which M is a divalent transition metal ion
(3).
1.2 CDGSH-type iron-sulfur domain-containing proteins
The CDGSH Iron-Sulfur domain (CISD) is a type of ancient and widely distributed motif
that are found in the three domains of life. This motif is characterized by a highly conserved
2

seventeen amino acid sequence [C-X-C-X2-(S/T)-X3-P-X-C-D-G-(S/A/T)-H], in which the
[2Fe-2S] cluster is coordinated with unique three cysteine residues (3Cys) and one histidine
(1His) in proteins (14-18). The most important character of this 3Cys-1His domain is that the
ISC attached to it has a higher redox midpoint potential and relatively lower binding stability.
Thus, it may serve as an electron donor or the ISC donor (19-31). The versatile function of the
CISD proteins may explain why they widely appear in bacteria, archaea, and eukaryotic cells
(Figure.1.2).
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Figure.1.2 Phylogenetic distribution of CISDs. (14)

1.3 Human NEET-protein family and related diseases
There are three CISD proteins, mitoNEET, Miner1, and Miner2, encoded by gene
CISD1, CISD2, and CISD3 respectively in human mitochondira. The first member of NEET
4

family, mitoNEET, was discovered during the screening for the mitochondrial binding targets of
the type II diabetes Pioglitazone (32). MitoNEET was named by its mitochondrial localization
(mito), and a sequence of amino acid residues ASN-Glu-Glu-Thr (NEET) (15). The rest of the 2
NEET-protein family members were named Miner1/2 meaning mitoNEET related 1/2 initially.
The three NEET family proteins share the CDGSH motif that holds a [2Fe-2S] clusters (16). The
UV-vis spectra of mitoNEET, Miner1, and Miner2 show great similarity (Figure.1.3) (33).
Further structure studies have shown that mitoNEET and Miner1 are homodimer, with
one CISD on each peptide chain, whereas Miner2 has two CISDs, each holding one [2Fe-2S]
cluster (17-18) (33). Both mitoNEET and Miner1 are lipid anchored proteins. MitoNEET is
anchored to the mitochondrial outer membrane via its N-terminal domain. The C-terminal
domain binds a [2Fe-2S] cluster and is exposed to cytosol (32). The mitoNEET homolog Miner1
is mainly associated with the endoplasmic reticulum (ER), with some in the mitochondrial outer
membrane (35). Miner2 is a soluble protein in the matrix (36-37). Extensive studies have shown
that mitoNEET and Miner1 play key roles in maintaining cellular iron content and production of
reactive oxygen species (ROS). MitoNEET was found to have a key role in in mitochondrial
morphology maintaining, cancer cell proliferation, lipid and glucose homeostasis in obesity and
diabetes. The mutations of Miner1 have been associated with the Wolfram Syndrome 2, a genetic
neurological disorder (38-48). The biological function of Miner2, however, is currently
unknown.
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Fig. 1.3 Human NEET protein alignments and UV–vis spectra.
(A) Amino acids conserved in humans are shown in gray. Amino acids that coordinate to the
2Fe –2S clusters are shown in yellow. The 16 amino acid cluster binding domains are boxed in
magenta. Note that Miner2 has a repeat of the 16 amino acid 2Fe–2S cluster binding domain,
underlined in pink. The transmembrane domains of mitoNEET and NAF-1 are highlighted by a
blue box. (B) UV–vis spectra of mitoNEET, NAF-1 and Miner2. Note the similarities of the peak
positions in the visible region which are ligand to metal charge transfer bands reflecting the
presence of the same type of Fe–S clusters and the similarity of their coordinations (34).
1.4. Structure and biochemical properties of mitoNEET
The whole length of human mitoNEET is 108 amino acid residues. The first 32 residues
serve as the hydrophobic lipid anchor, and the rest residues forming the major soluble part facing
plasma. The soluble part has two major domains, a hydrophilic β-cap structure at top, and a helix
enriched domain cradling [2Fe-2S] clusters close to the mitochondrial outer membrane (Figure
1.4). The [2Fe-2S] is buried in hydrophobic core and coordinated with Cys-72, Cys-74, Cys83,
and His-87 (15). Two major binding sites of type II diabetes drugs pioglitazone has been
identified. Lys-42 and Ala-43 from chain 1 and Met-44, Leu-47, Arg-76, His-90, and Thr-94
from chain 2 forms site 1, and His-48, Ile-49, Trp-75, Arg-76, Ser-77, and Lys-78 from chain 1
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forms site 2 (49). In our studies, we have also identified a unique FMN binding site which is
different from, but overlaps with, site 1 and site 2 of mitoNEET (26).
The redox midpoint potential of the mitoNEET [2Fe-2S] cluster is 0 mV at pH 7, which
is 300 mV higher than the 4-Cys mutant [2Fe-2S] (H87C) in mitoNEET. Previous studies have
proven that the reduced [2Fe-2S] could be oxidized by hydrogen oxide, and the oxidized [2Fe2S] could be reduced by biological thiols, including reduced glutathione, L-cysteine or N-acetylL-cysteine, and dithiothreitol (ref). E. coli thioredoxin/thioredoxin reductase system, and
NADPH dependent human glutathione reductase could also reduce the mitoNEET ISC in (ref).
Pioglitazone could block the mitoNEET [2Fe-2S] cluster from reduction by biological thiols (2426). Another function of pioglitazone is that it may stabilize the [2Fe-2S] cluster in mitoNEET
(15).
1.5 Iron-Sulfur cluster protein is the sensor of nitric oxide
Nitric oxide (NO) is a hydrophobic molecule that can easily penetrate the cell membrane.
The highly reactive NO can then react with ROS, thiols, etc. and generate S-nitrosothiols,
nitrogen dioxide, peroxynitrite, dinitrogen trioxide, and nitrite (50). This feature explains why
the immune system of higher animals uses NO as cytotoxin in the first line of defense against the
invading pathogens. NO also serves as a key signaling molecule in the muscular and nervous
system of higher animals (51-54).
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Figure.1.4 Overall structural organization and domain topology of dimeric mitoNEET.
(A Upper) The backbone tracing of each protomer colored in green and magenta, respectively,
together with the 2F o − F c electron density (gray) map contoured at 1.5σ. The protomers pack
in a parallel fashion with each protomer harboring a 2Fe–2S cluster, depicted as yellow (sulfur)
and red (iron) spheres; N and C termini are indicated. (Lower) The box shows an expanded view
of one 2Fe–2S cluster (rotated ≈90° from upper view) and ligands and the corresponding
2F o − F celectron density (gray) map contoured at 2.0σ. (B) Ribbon diagram highlighting the
two domains of the mitoNEET dimer. A six-stranded β-sandwich forms the intertwined β-cap
domain and a larger cluster-binding domain carries two 2Fe–2S clusters. (C) A topology diagram
highlighting the organization of the secondary structural units (numbered) illustrates the strand
swap between protomers. (D) Coded segments contributing to each domain are highlighted on
the primary sequence and block diagram. Protomer sequences within the cluster-binding domain
are colored in purple and dark green, and the sequences corresponding to the β-cap domain are
given in pink and light green, respectively. The amino acid sequence of the resolved amino acid
strand is shown in the box with the cluster and cap regions colored as for protomer A; the
numbers indicate the first (Lys-42) and last (Lys-106) resolved amino acid. The ligands to the
2Fe–2S cluster shown in the expanded boxed view in A are indicated in bold and highlighted in
gray. The 2Fe–2S binding cradle is located sequentially between two partial β-cap domains.
Rendered with Pymol (15).
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There are a serious of ISC proteins, mainly transcriptional regulators, in E. coli that could
sense NO and adapt the metabolism of the cells to this stress, including MetR, IscR, Fur, FNR,
and SoxR (55-59). The NO molecule interacts with the iron-sulfur cluster in proteins and results
in disruption of the cluster and formation of dinitrosyl iron complexes (DNICs) (60).
(Figure.1.5.) The NO-modified sensor can then regulate downstream gene transcription (61-63).
The DINCs in proteins can be repaired by re-assembly of new iron-sulfur clusters (59) (64). For
example, the [2Fe-2S] cluster of SoxR remains reduced in vivo under normal condition. Upon
NO stress, the SoxR ISC interacts with NO, and produces SoxR containing dinitrosyl iron
complex (DNIC) which is active to stimulate the gene expression in cells (65).

Figure. 1.5 Scheme of dinitrosyl iron complexes (DNICs) formation and reparation.
9

(A) Nitric Oxide could disrupt the [Fe-S] or binds with non-heme iron in cell to form the DNIC.
(B) Mechanisms in cell to repair the DNIC.
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CHAPTER 2. ELECTRON TRANSFER ACTIVITY OF MITONEET
2.1 Introduction
Pioglitazone is a drug prescribed for the treatment of type II diabetes (1). In addition to
acting on the peroxisome proliferator activated receptor gamma (PPAR) which regulates
expression of the genes related to insulin sensitivity (2), pioglitazone also has a rapid
pharmacological effect on energy metabolism in mitochondria (3). Search of the
pioglitazonebinding targets revealed a new protein, mitoNEET, which localizes in the
mitochondrial outer membrane (4). In mice, deletion of mitoNEET results in decrease of
oxidative phosphorylation capacity in mitochondria by about 30% (5). On the other hand,
overexpression of mitoNEET enhances lipid storage and decreases oxidative damage in
adipocytes (6,7), and inhibits ferroptosis in human hepatocellular carcinoma cells (8). In beta
cells, increased expression of mitoNEET leads to hyperglycemia and glucose intolerance (9). In
spinal neurons, microRNA-127 has been shown to specifically target expression of mitoNEET,
and depletion of mitoNEET results in neuronal loss and apoptosis (10). In breast cancer cells,
mitoNEET is highly expressed, and depletion of mitoNEET inhibits cancer cell proliferation
(11,12). It has thus been postulated that mitoNEET is a key regulator of energy metabolism in
mitochondria (13), and an attractive chemotherapeutic target for treating the mitochondriarelated human diseases (14-17).

This chapter previously published as: Wang, Yiming, Aaron P. Landry, and Huangen Ding. "The
mitochondrial outer membrane protein mitoNEET is a redox enzyme catalyzing electron transfer
from FMNH2 to oxygen or ubiquinone." Journal of Biological Chemistry 292.24 (2017): 1006110067.
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Crystallographic studies have shown that mitoNEET is a homodimer with each monomer
hosting a [2Fe-2S] cluster via an unusual ligand arrangement of three cysteine and one histidine
residues in its C-terminal cytosolic domain (18- 21). The N-terminus of mitoNEET has a
transmembrane -helix which anchors the protein to the mitochondrial outer membrane (4).
However, the mechanism by which mitoNEET regulates energy metabolism in mitochondria still
remains elusive. One hypothesis stated that mitoNEET may transfer its [2Fe-2S] clusters to apoproteins such as apo-ferredoxin (22), the iron regulatory protein-1 (IRP-1) (23), or anamorsin, a
protein required for iron-sulfur cluster assembly in cytosol (24). Because mitochondria are the
primary sites for iron-sulfur cluster biogenesis in cells (25), it is tempting to propose that
mitoNEET is a carrier transporting the clusters assembled in mitochondria to target proteins in
cytosol (22-24). However, the observed cluster transfer occurs only when the mitoNEET [2Fe2S] clusters are oxidized (22,23), and the mitoNEET [2Fe-2S] clusters are mostly in a reduced
state in cells under normal physiological conditions (26-29). Thus, the exact role of mitoNEET in
iron-sulfur cluster biogenesis has yet to be further defined. An alternative hypothesis was that
mitoNEET may regulate mitochondrial functions via proteinprotein interactions. This hypothesis
was based on the observations that mitoNEET interacts with mitochondrial proteins including the
Parkinson's disease associated protein Parkin (9), the mitochondrial outer membrane import
complex protein 1 (MTX1) (30), glutathione reductase (28), and glutamate dehydrogenase 1
(31). Nevertheless, no direct evidence is available suggesting that the function of mitochondrial
proteins are regulated by mitoNEET.
In previous studies, we have found that human mitoNEET has a specific interaction with
the reduced flavin mononucleotide (FMNH2), and that FMNH2 can rapidly reduce the
mitoNEET [2Fe-2S] clusters (29). Here, we report that the reduced mitoNEET [2Fe-2S] clusters
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can be oxidized by oxygen or ubiquinone-2. Compared with oxygen, ubiquinone-2 appears to be
more efficient in oxidizing the mitoNEET [2Fe-2S] clusters, indicating that ubiquinone may act
as a native electron acceptor of the reduced mitoNEET [2Fe-2S] clusters in mitochondria. In the
presence of flavin reductase which reduces FMN to FMNH2 using NADH as the electron donor,
mitoNEET mediates oxidation of NADH with a concomitant reduction of oxygen or ubiquinone2. Furthermore, pioglitazone can effectively inhibit the electron transfer activity of mitoNEET by
forming a unique complex with mitoNEET and FMNH2. The results led us to propose that
mitoNEET is a redox enzyme that may promote oxidation of NADH to enhance glycolysis in
cytosol, and that pioglitazone may regulate energy metabolism in mitochondria by inhibiting the
electron transfer activity of mitoNEET.

2.2 Materials and Methods
Protein preparation
Human mitochondrial outer membrane protein mitoNEET33–108 (containing residues
33-108) was purified as described in (28). Escherichia coli flavin reductase (Fre) was prepared
using an E. coli strain hosting an expression plasmid encoding Fre from the ASKA library (46).
Both mitoNEET and Fre were overproduced in E. coli cells, and purified using Ni-agarose
columns, followed by passing through a High-Trap Desalting column. The purity of purified
proteins was greater than 95% as judged by electrophoresis analysis on a 15% polyacrylamide
gel containing SDS followed by staining with Coomassie Blue. The protein concentrations of
mitoNEET and E. coli Fre were measured at 280 nm using the molar extinction coefficients of
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8.6 and 26.4 mM-1 cm-1, respectively. The molar extinction coefficients were calculated based
on the protein primary sequence.
Redox state of the mitoNEET [2Fe-2S] clusters
Reduction and oxidation of the mitoNEET [2Fe-2S] clusters in incubation solutions were
monitored using a Beckman DU640 UV-visible absorption spectrometer equipped with a
temperature controller. Oxidized mitoNEET [2Fe-2S] clusters have two major absorption peaks
at 455 nm and 540 nm, while reduced mitoNEET [2Fe-2S] clusters have the absorption peaks at
420 nm and 540 nm (29). The redox state of the mitoNEET [2Fe-2S] clusters was further
determined by EPR measurements. Oxidation of NADH in the incubation solution was
monitored at 340 nm after subtracting the basal absorption of proteins the incubation solution.
Anaerobic conditions were achieved by purging the incubation solutions with pure argon gas for
15 min in a sealed vial.
EPR measurements
The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a
Bruker model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power,
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30 K;
receiver gain, 2x105.
Chemicals
NADH, NADPH, Isopropyl-β-D-1- thiogalactopyranoside, kanamycin, and ampicillin
were purchased from Research Product International co. FMN, FAD, ubiquinone-2, pioglitazone,
NL-1, and other chemicals were purchased from Sigma co. The molar extinction coefficients of
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6.2 mM-1 cm-1 at 340 nm, 12.5 mM1 cm-1 at 445 nm, and 11.3 mM-1 cm-1 at 450 nm were
used for measuring the concentration of NADH/NADPH, FMN and FAD, respectively (43). The
molar extinction coefficient of 14.9 mM1 cm-1 at 278 nm was used for ubiquinone-2.

2.3 Results
Reduction of the mitoNEET [2Fe-2S] clusters under Anaerobic and Aerobic conditions
Previous studies have shown that human mitoNEET has a specific interaction with
FMNH2, and that FMNH2 can quickly reduce the mitoNEET [2Fe-2S] clusters (29). As oxygen
would be present in mitochondria, we asked whether oxygen will have any effects on the
FMNH2-mediated reduction of the mitoNEET [2Fe-2S] clusters.
To test this idea, human mitoNEET was preincubated with FMN and NADH under
anaerobic or aerobic conditions. The reaction was initiated by adding a catalytic amount of E.
coli flavin reductase (32) to reduce FMN using NADH as the electron donor (29). Figure 2.1A
shows that under anaerobic conditions, the oxidized mitoNEET [2Fe-2S] clusters (indicated by
the absorption peaks at 455 nm and 540 nm (27)) were quickly reduced upon addition of flavin
reductase, as reported previously (29). About 10 M NADH was oxidized when 10 M
mitoNEET [2Fe-2S] clusters were reduced in the incubation solution under anaerobic conditions
(Figure 2.1C). Under aerobic conditions, the mitoNEET [2Fe-2S] clusters were also fully
reduced after addition of flavin reductase (Figure 2.1B). However, NADH was continuously
oxidized even after the mitoNEET [2Fe-2S] clusters were fully reduced (Figure 2.1C). The
observed oxidation of NADH was mitoNEET-dependent, as only a very small amount of NADH
was oxidized in the same incubation solution without mitoNEET under aerobic conditions
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(Figure 2.1D). Thus, mitoNEET is able to promote oxidation of NADH in the presence of flavin
reductase and FMN under aerobic conditions.

Figure 2.1 Reduction of the mitoNEET [2Fe-2S] clusters by FMNH2 under aerobic and
anaerobic conditions.
MitoNEET (containing 10 M [2Fe-2S] clusters) was incubated with FMN (0.1 M) and NADH
(fig. caption cont'd.)
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(60 M) under anaerobic (A) and aerobic (B) conditions. Flavin reductase (Fre) (0.1 M) was
then added to the solutions to initiate the reaction. UV-visible absorption spectra were taken
every 80 seconds after addition of Fre for 560 seconds. Absorption peaks at 455 nm and 540 nm
represent the oxidized mitoNEET [2Fe-2S] clusters. C), time courses of NADH oxidation in the
incubation solutions containing mitoNEET, Fre and FMN under anaerobic (A) (closed circles) or
aerobic (B) (open circles) conditions. The amount of NADH in the incubation solutions was
measured from the absorption peak at 340 nm after subtracting the absorption of proteins in the
incubation solutions. D), same as in B) except no mitoNEET was included. The data were
representatives of three independent experiments.
The reduced mitoNEET [2Fe-2S] clusters are oxidized by oxygen under aerobic conditions
In the presence of flavin reductase, FMN and excess NADH, the mitoNEET [2Fe-2S]
clusters were fully reduced under aerobic conditions (Figure 2.1B). One explanation could be
that the reduced mitoNEET [2Fe-2S] clusters are oxidized by oxygen and rapidly re-reduced by
FMNH2/NADH/flavin reductase under aerobic conditions. To test this idea, mitoNEET was
incubated with a limited amount of NADH and FMN under aerobic conditions. As shown in
Figure 2.2, the mitoNEET [2Fe-2S] clusters were fully reduced upon addition of a catalytic
amount of flavin reductase. However, when NADH in the incubation solution was completely
oxidized, the reduced mitoNEET [2Fe-2S] clusters were gradually re-oxidized under aerobic
conditions, demonstrating that the reduced mitoNEET [2Fe2S] clusters are indeed oxidized by
oxygen under aerobic conditions.
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Figure 2.2 Oxidation kinetics of the reduced mitoNEET [2Fe-2S] clusters by oxygen.
MitoNEET (containing 10 M [2Fe-2S] clusters) was incubated with FMN (0.1 M) and NADH
(20 M) under aerobic conditions. Flavin reductase (Fre) (0.1 M) was then added to the
incubation solution to initiate the reaction. The amount of NADH in the incubation solution was
measured from the absorption peak at 340 nm. The amount of the reduced mitoNEET [2Fe-2S]
clusters was measured from the different absorption at the absorption peaks of 455 nm and 420
nm. The amounts of NADH and the reduced mitoNEET [2Fe-2S] clusters in the incubation
solution were plotted as a function of incubation time. The data were representatives of three
independent experiments.

The reduced mitoNEET [2Fe-2S] clusters can also be oxidized by ubiquinone
2 under anaerobic conditions–In mitochondria, the NADH-ubiquinone oxidoreductase
(complex I) oxidizes NADH and reduces ubiquinone via FMN and a chain of iron-sulfur clusters
(33). Ubiquinone is a key electron transport component in respiratory chain (34), and is present
in both mitochondrial inner and outer membranes (35). As mitoNEET is a mitochondrial outer
membrane protein (4), and the [2Fe-2S] clusters in mitoNEET are positioned close to the
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membrane (18-21), we postulated that the reduced mitoNEET [2Fe-2S] clusters may also reduce
ubiquinone in the mitochondrial outer membrane.
In the experiments, the mitoNEET [2Fe-2S] clusters were pre-reduced with flavin
reductase, FMN, and an excess amount of NADH under anaerobic conditions. Ubiquinone-2, a
ubiquinone-10 analog, was then injected to the incubation solution anaerobically using a gastight
syringe. Figure 2.3 shows that the reduced mitoNEET [2Fe-2S] clusters were immediately
oxidized upon injection of ubiquinone-2 under anaerobic conditions. In control, injection of
degassed water had no effect on the reduced mitoNEET [2Fe-2S] clusters. After further
incubation, the ubiquinone-2- oxidized mitoNEET [2Fe-2S] clusters were fully re-reduced in the
incubation solution (Figure 2.3A), suggesting that oxidation of the mitoNEET [2Fe2S] clusters
by ubiquinone-2 is reversible.
We also tested whether the reduced mitoNEET [2Fe-2S] clusters could be oxidized by
other oxidants. In the experiments, the mitoNEET [2Fe-2S] clusters were pre-reduced with flavin
reductase, FMN, and an excess amount of NADH under anaerobic conditions, followed by
injection of oxidants anaerobically. We found that DCIP (dichlorophenolindophenol),
K3Fe(CN)6 or menadione could all quickly oxidize the reduced mitoNEET [2Fe-2S] clusters,
suggesting that the reduced mitoNEET [2Fe-2S] clusters may also be oxidized by other oxidants
in cytosol. Oxidation of the mitoNEET [2Fe-2S] clusters by DCIP or K3Fe(CN)6 was very
similar to that of ubiquinone-2. However, menadione appeared to be less active to oxidize the
mitoNEET [2Fe-2S] clusters under the experimental conditions. Since ubiquinone is a
physiological oxidant and is in the vicinity of the mitoNEET [2Fe-2S] clusters in mitochondria,
we propose that ubiquinone could be a native electron acceptor for the reduced mitoNEET [2Fe2S] clusters in mitochondria.
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Figure 2.3 Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under
anaerobic condition.
A), oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under anaerobic
conditions. MitoNEET (containing 10 M [2Fe-2S] clusters) was reduced with FMN (0.1 M)
and NADH (50 M) and flavin reductase (0.1 M) under anaerobic conditions. Ubiquinone-2
(Q2) (20 M) was injected into the incubation solution anaerobically as indicated. The reduced
mitoNEET [2Fe-2S] clusters were measured from the different absorption at the absorption
peaks of 455 nm and 420 nm, and plotted as function of the incubation time. B), UV-visible
absorption spectra of mitoNEET. Spectra were taken before (spectrum 1) and after (spectrum 2)
addition of NADH (50 M). Spectrum 3, right after anaerobic addition of ubiquinone-2 (20 M).
The experiments were repeated three times. Similar results were obtained.
Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under aerobic
conditions
Compared with oxygen (Figure 2.2), ubiquinone-2 is much more efficient in oxidizing
the reduced mitoNEET [2Fe-2S] clusters (Figure 2.3A). To further explore the reactivity of the
reduced mitoNEET [2Fe-2S] clusters with oxygen and ubiquinone-2, we incubated mitoNEET
with FMN, NADH and ubiquinone-2 under aerobic conditions. Figure 2.4A shows that NADH
was continuously oxidized after flavin reductase was added to the incubation solution. The
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observed NADH oxidation was mitoNEET-dependent, as only a very small amount of NADH
was oxidized in the incubation solution without mitoNEET under aerobic conditions (Figure
2.4B). Importantly, despite oxidation of NADH in the incubation solution containing
ubiquinone-2, the mitoNEET [2Fe-2S] clusters remained oxidized during the incubation process
(Figure 2.4A). This result indicated that the reduced mitoNEET [2Fe-2S] clusters might be
rapidly oxidized by ubiquinone2 which subsequently transferred electron to oxygen under
aerobic conditions. Indeed, when the incubation solution in Figure 2.4A was purged with pure
argon gas to remove oxygen, the mitoNEET [2Fe-2S] clusters were re-reduced upon addition of
NADH (Figure 2.4C and D). Thus, the results further suggest that ubiquinone in mitochondria
may act as an intrinsic electron acceptor for the mitoNEET [2Fe-2S] clusters under anaerobic or
aerobic conditions.
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Figure 2.4 Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under aerobic
condition.
A), mitoNEET (containing 10 M [2Fe-2S] clusters) was pre-incubated with FMN (0.1 M),
NADH (50 M), and ubiquinone-2 (20 M) under aerobic conditions. UV-visible absorption
spectra were taken every 40 seconds after addition of Fre (0.1 M) for 320 seconds. The amount
of NADH in the incubation solution was measured from the absorption peak at 340 nm. B), same
as A), except mitoNEET was not included in the incubation solution. C), the incubation solution
in A) was purged with pure argon gas for 10 min, followed by injection of NADH (50 M)
(fig. caption cont'd.)
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anaerobically. UV-visible absorption spectra were taken every 40 seconds for 320 seconds. D),
redox transition of the mitoNEET [2Fe-2S] clusters under aerobic and anaerobic conditions. The
data were from panels A) and C). The amount of the reduced mitoNEET [2Fe-2S] clusters was
measured from the different absorption at the peaks of 455 nm and 420 nm in each spectrum.
The data were representatives of three independent experiments.
A pioglitazone analog NL-1 inhibits the electron transfer activity of mitoNEET
MitoNEET was identified as a target of the type II diabetes drug pioglitazone (1).
However, pioglitazone has a very low solubility in water (<1 mg/ml), making it difficult to
characterize its biochemical activity (28). A new pioglitazone analog, NL-1 or 5-(3,5-di-tertbutyl-4hydroxybenzyl)-4-hydroxythiazol-2(5H)-one, was designed and synthesized by
Geldenhuys, et al. (36). NL-1 has been improved for its solubility in water and binding
specificity to mitoNEET. It has similar pharmacological activities as pioglitazone to decrease
the maximal respiration rate of mitochondria by 45%, reduce the production of reactive oxygen
species (36), and improve the cell survival of cardiac stem cells during oxidative stress (37).
Here, we explored the effect of NL-1 on the electron transfer activity of mitoNEET. In
the experiments, mitoNEET was pre-incubated with increasing concentrations of NL-1 under
aerobic conditions, followed by addition of flavin reductase and FMN. The reaction was
initiated by adding NADH. The amounts of the reduced mitoNEET [2Fe-2S] clusters in the
incubation solutions were monitored spectroscopically, and plotted as a function of incubation
time. Figure 2.5 shows that as the concentration of NL-1 increased, the reduction of the
mitoNEET [2Fe-2S] clusters in the incubation solution gradually decreased. At 250 µM NL-1,
the reduction of the mitoNEET [2Fe-2S] clusters (10 µM) in the incubation solution was
inhibited by about 70%, indicating that NL-1 can effectively block the electron transfer activity
of mitoNEET.
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Figure 2.5 Inhibition of the electron transfer activity of mitoNEET by the pioglitazone analog
NL-1.
MitoNEET (containing 10 M [2Fe-2S] clusters) was pre-incubated with increasing
concentrations of NL1 (from 0 to 250 M) at room temperature for 30 min under aerobic
conditions, followed by addition of FMN (0.1 M) and flavin reductase (0.1 M). NADH (50
M) was then added to the incubation solutions to initiate the reaction. The amount of the
reduced mitoNEET [2Fe-2S] clusters in the incubation solutions was measured from the different
absorption at the absorption peaks of 455 nm and 420 nm and plotted as function of the reaction
time after injection of NADH. The data are representatives from three independent experiments.

Pioglitazone/NL-1 and FMNH2 forms a unique complex with the reduced mitoNEET [2Fe2S] cluster
To further assess the effects of pioglitazone and its analog NL-1 on the electron transfer
activity of mitoNEET, mitoNEET was incubated with FMN, pioglitazone, NL-1, or the
combinations at room temperature for one hour under aerobic conditions. The samples were then
reduced with sodium dithionite for the electron paramagnetic resonance (EPR) measurements of
the reduced mitoNEET [2Fe-2S] clusters. Figure 2.6A shows that incubation with FMNH2
results in a small EPR signal at g = 1.85 of the reduced mitoNEET [2Fe-2S] clusters (spectrum
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2), as reported previously (29). However, unlike FMNH2, incubation with pioglitazone (4)
(spectrum 3) or NL-1 (36) (spectrum 4) did not change the EPR spectrum of the reduced
mitoNEET [2Fe-2S] clusters. Nevertheless, incubation of mitoNEET with FMNH2 and
pioglitazone completely shifted the typical EPR spectrum at g = 1.94 of the reduced mitoNEET
[2Fe-2S] clusters to a new EPR spectrum with g = 1.85 (spectrum 5). Same result was also
observed when mitoNEET was incubated with FMNH2 and NL-1 (spectrum 6). A small EPR
signal at g = 1.86 of the reduced mitoNEET [2Fe-2S] clusters was previously noticed (38).
Although the interpretation of the EPR signal at g = 1.85 remains elusive, the dramatic change of
the EPR spectrum suggests that FMNH2 and pioglitazone/NL-1 may have a close interaction
with the reduced [2Fe-2S] clusters in mitoNEET, or that binding of FMNH2 and
pioglitazone/NL-1 may result in conformational changes that alter the structural orientation of
the cluster ligands in mitoNEET.
MitoNEET was further incubated with a fixed concentration of FMN and increasing
concentrations of NL-1 at room temperature for one hour under aerobic conditions, followed by
reduction with sodium dithionite. Figure 2.6B shows that as the concentration of NL-1 increased,
the EPR signal at g = 1.85 also gradually increased. About 200 M NL-1 was sufficient to
change the EPR spectrum of the g = 1.94 to that of the g = 1.85 of the reduced mitoNEET [2Fe2S] clusters. The results suggested that FMNH2 and pioglitazone/NL-1 have a synergistic effect
on the reduced mitoNEET [2Fe-2S] clusters.
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Figure 2.6 Synergistic effect of FMNH2 and pioglitazone/NL-1 on the reduced mitoNEET [2Fe2S] clusters.
A), EPR spectra of the reduced mitoNEET [2Fe-2S] clusters. MitoNEET (containing 20 M
[2Fe-2S] clusters) (spectrum 1) was incubated with FMN (50 M) (spectrum 2), pioglitazone
(Pio) (500 M) (spectrum 3), NL-1 (200 M) (spectrum 4), FMN + pioglitazone (Pio) (spectrum
5), FMN + NL-1 (spectrum 6) at room temperature for 60 minutes. After incubation, samples
were reduced with freshly prepared sodium dithionite (4 mM), transferred to EPR tubes, and
immediately frozen in liquid nitrogen for EPR measurements. B), titration of NL-1. MitoNEET
(containing 20 M [2Fe-2S] clusters) was incubated with FMN (50 M) and increasing
concentrations of NL-1 (0 to 200 M) (spectra 1-5) at room temperature for 60 min. After
incubation, samples were reduced with freshly prepared sodium dithionite (4 mM), transferred to
EPR tubes, and immediately frozen in liquid nitrogen for EPR measurements. The data were
representatives of three independent experiments.
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2.4 Discussion
MitoNEET is a founding member of a small family of proteins that contain a CDGSH
(CysAsp-Gly-Ser-His) motif (39,40). Although it has been reported that mitoNEET is a key
regulator of energy metabolism in mitochondria (13), the underlying mechanism has not been
fully understood. Several research groups proposed that mitoNEET may transfer its [2Fe-2S]
clusters for maturation of iron-sulfur proteins in cytosol (22- 24). Others suggested that
mitoNEET may regulate mitochondrial functions via specific protein-protein interactions (9).
Here, we report that mitoNEET is a novel redox enzyme that transfers electron from FMNH2 to
oxygen or ubiquinone in the mitochondrial outer membrane via its [2Fe-2S] clusters. In this
process, FMNH2, which may be reduced by flavin reductase (41) and NADH in cytosol, binds to
mitoNEET and reduces the [2Fe-2S] clusters in mitoNEET (29). The reduced mitoNEET [2Fe2S] clusters are readily oxidized by oxygen or ubiquinone (Figure 2.7). Together with flavin
reductase (41) and FMN, mitoNEET may effectively promote oxidation of NADH in cytosol
with a concomitant reduction of oxygen or ubiquinone in the mitochondrial outer membrane.
The intracellular concentration of FMN in human cells is in nanomolar range (42). Here
we find that 100 nM FMN is sufficient to reduce 10 M mitoNEET [2Fe-2S] clusters in the
presence of flavin reductase and NADH in less than 2 min (Figure 2.1), indicating that FMN may
act as an electron shuttle reducing the mitoNEET [2Fe-2S] clusters (29). In cytosol, FMN is
reduced to FMNH2 by flavin reductase (41) using NADH as the electron donor. Because
glycolysis will produce NADH which must be oxidized in order to sustain glycolysis activity
(43), mitoNEET may enhance glycolysis by promoting oxidation of NADH in cytosol (Figure
2.7). In primary and metastatic cancer cells, glycolysis is highly upregulated, resulting in
increased glucose consumption (44). Interestingly, mitoNEET is also highly expressed in cancer
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cells and over expression of mitoNEET is essential for cancer cell proliferation (11,12). In this
context, we propose that overproduced mitoNEET may enhance glycolysis in cytosol by
promoting oxidation of NADH in cancer cells. Accordingly, when mitoNEET is deleted,
oxidation of NADH in cytosol could be diminished, leading to decrease of glycolysis in cytosol
and oxidative phosphorylation in mitochondria. This notion is consistent with the previous report
showing that deletion of mitoNEET decreases oxidative phosphorylation capacity in
mitochondria by about 30% (5) and inhibits cancer cell proliferation (11,12). Nevertheless,
additional experiments are required to elucidate the physiological link between the electron
transfer activity of mitoNEET and glycolysis in cells.
Iron-sulfur clusters in proteins are often sensitive to oxygen and reactive oxygen species
(45). However, the mitoNEET [2Fe-2S] clusters are highly resistant to oxygen and hydrogen
peroxide (27). In fact, the reduced mitoNEET [2Fe-2S] clusters can be oxidized by oxygen
without disruption of the cluster (Figure 2.2). Importantly, compared with oxygen, ubiquinone2
is more efficient in oxidizing the reduced mitoNEET [2Fe-2S] clusters (Figures 2.3 and 2.4).
Since mitoNEET is a mitochondrial outer membrane protein (4), and the [2Fe-2S] clusters in
mitoNEET are positioned close to the membrane (18-21), we propose that ubiquinone could be
an intrinsic electron acceptor for the reduced mitoNEET [2Fe-2S] clusters (Figure 2.7). Upon the
single-electron reduction by the reduced mitoNEET [2Fe-2S] cluster, ubiquinone is converted to
semiquinone which may be further reduced to ubihydroquinone, or transfer the electron to
oxygen to produce superoxide or hydrogen peroxide (34). While other oxidants in cytosol may
also oxidize the reduced mitoNEET [2Fe-2S] clusters in cytosol, the proposed electron transfer
path from NADH to ubiquinone catalyzed by the mitoNEET [2Fe-2S] clusters (Figure 2.7) is
reminiscent of the electron transfer path in complex I in which electrons in NADH are
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transferred to ubiquinone via FMN and a chain of iron-sulfur clusters (33). The observed
reduction of oxygen by the mitoNEET [2Fe-2S] clusters may reflect the possible electron
transfer leak in mitoNEET, as reported in complex I (33). The final products of the electron
transfer reaction catalyzed by mitoNEET in mitochondria remain to be determined.
Pioglitazone has two major targets in cells: PPAR that regulates the expression of genes
involved in insulin sensitivity (2) and mitoNEET (4) that modulates energy metabolism in
mitochondria (3). It was previously reported that binding of pioglitazone stabilizes the
mitoNEET [2Fe-2S] clusters (21) and shifts the redox midpoint potential of the [2Fe-2S] clusters
by about 100 mV (26). Here, we find that pioglitazone and its analog NL-1 (36) can inhibit the
electron transfer activity of mitoNEET (Figure 2.5) by forming a unique complex with
mitoNEET and FMNH2 which has an unusual EPR signal at g = 1.85 (Figure 2.6). Based on the
molecular docking modeling (29,36), FMN and pioglitazone/NL-1 have distinct binding sites but
with significant overlap in mitoNEET, suggesting that pioglitazone/NL-1 may interfere the
FMNH2 binding in mitoNEET and inhibit the electron transfer activity of mitoNEET in
mitochondria. As mitoNEET is proposed as a chemotherapeutic target for treating type II
diabetes (4), breast cancer (16,17), and neurodegenerative diseases (10), a high-throughput
screening approach combining the electron transfer activity assay and EPR measurements of
mitoNEET may help identify new drugs that specifically target the mitoNEET [2Fe-2S] clusters
in mitochondria.
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Figure 2.7 A proposed model for the electron transfer of mitoNEET in mitochondria outer
membrane.
In cytosol, FMNH2 is reduced by flavin reductase using NADH as the electron donor. FMNH2
then reduces the mitoNEET [2Fe-2S] clusters which in turn transfer electrons to oxygen or
ubiquinone in the mitochondrial outer membrane. Together with flavin reductase and FMN,
mitoNEET promotes NADH oxidation with a concomitant reduction of oxygen or ubiquinone in
mitochondria.
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CHAPTER 3. LIGHT-INDUCED RELEASE OF NITRIC OXIDE FROM
THE NITRIC OXIDE-BOUND CDGSH-TYPE [2FE–2S] CLUSTERS IN
MITOCHONDRIAL PROTEIN MINER2
3.1 Introduction
Iron-sulfur proteins are involved in diverse physiological functions ranging from energy
metabolism to DNA replication and repair [1]. Most iron-sulfur clusters in proteins are ligated
via cysteine residues. However, other amino acid residues such as histidine, glutamine, serine, or
arginine may also provide ligands for iron-sulfur clusters in proteins [2]. A new group of ironsulfur proteins that contain the CDGSH (Cys-Asp-Gly-Ser-His) motifs have recently been
identified [3]. Each CDGSH motif in the protein hosts a [2Fe–2S] cluster via a unique ligand
arrangement of three cysteine and one histidine residues. In human mitochondria, there are three
CDGSH-type iron-sulfur proteins [3,4]: mitoNEET [5], a mitoNEET-related protein 1 (Miner1
or NAF-1) [6], and a mitoNEET-related protein 2 (Miner2) [7,8]. MitoNEET was initially
identified as a target of the type II diabetes drug pioglitazone [5]. Miner1 and mitoNEET are
homologues with 54% identity and 76% similarity. Mutations of Miner1 have been attributed to
causing type II Wolfram Syndrome [9,10]. Both mitoNEET and Miner1 contain a
transmembrane alpha helix in the N-terminus and a CDGSH motif in the C-terminal domain that
hosts a [2Fe–2S] cluster [6,[11], [12], [13]]. While mitoNEET is a mitochondrial outer

This chapter previously published as: Wang, Yiming, Jeonghoon Lee, and Huangen Ding.
"Light-induced release of nitric oxide from the nitric oxide-bound CDGSH-type [2Fe–2S]
clusters in mitochondrial protein Miner2." Nitric Oxide (2019).
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membrane [5], Miner1 is localized in the mitochondrial outer membrane and the endoplasmic
reticulum membrane [14]. Increasing evidence suggests that mitoNEET and Miner1 have a
crucial regulatory role in cellular redox state, iron homeostasis, and production of reactive
oxygen species in mitochondria [15,16]. Interestingly, unlike mitoNEET and Miner1, Miner2 is a
soluble mitochondrial matrix protein and hosts two [2Fe–2S] clusters via two CDGSH motifs
[7,8]. While it has been proposed that Miner2 could be involved in iron-sulfur cluster biogenesis
in mitochondria [8], the physiological function of Miner2 remains largely elusive.
Iron-sulfur clusters in proteins are among the primary targets of nitric oxide (NO), as NO
has a specific reactivity with ferrous iron in proteins [[17], [18], [19], [20]]. A number of ironsulfur proteins have previously been characterized as NO sensors in cells [20]. It has been shown
that iron-sulfur clusters in proteins can be readily modified by NO forming the protein-bound
dinitrosyl iron complexes [18,21,22], the thiolate-bridged diiron tetranitrosyl complexes [23], or
the octa-nitrosyl clusters [24], depending on specific proteins and NO concentrations used in the
experiments. Unexpectedly, we have found that the CDGSH-type [2Fe–2S] clusters in Miner2
are able to bind NO and form the stable NO-bound [2Fe–2S] clusters without disruption of the
clusters [7]. In the present study, we report that the NO-bound Miner2 [2Fe–2S] clusters can
readily release NO upon light excitation in the visible range. The UV–visible and Electron
Paramagnetic Resonance (EPR) measurements show that the NO-bound Miner2 [2Fe–2S]
clusters are converted to the reduced Miner2 [2Fe–2S] clusters after NO is released upon the
light excitation, suggesting that NO binding in the reduced Miner2 [2Fe–2S] clusters is
reversible. Furthermore, NO binding effectively inhibits the redox transition of the Miner2 [2Fe–
2S] clusters. We propose that NO may modulate the function of Miner2 in mitochondria via
directly binding to the CDGSH-type [2Fe–2S] clusters in the protein.
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3.2 Materials and methods
Protein preparation
The gene encoding the human Miner2 (containing residues 34–127) with the N-terminal
His tag was synthesized (Genscript co.) and cloned into pET28b + plasmid for protein expression
in E. coli cells. The cloned DNA sequence was confirmed by direct sequencing (Eurofins MWG
Operon). Overnight E. coli cells containing expression plasmid were diluted 1:100 in freshly
prepared LB (Luria-Bertani) medium and incubated at 37 °C with aeration (250 rpm) for 3 h,
followed by protein induction by adding Isopropyl β-d-1-thiogalactopyranoside (200 μM)
overnight at 18 °C. The recombinant protein was purified as described previously [25]. The
purity of purified proteins was greater than 95% as judged by electrophoresis analysis on a 15%
polyacrylamide gel containing SDS followed by staining with Coomassie Blue. The NO-bound
Miner2 [2Fe–2S] clusters were prepared by treating the E. coli cells expressing human Miner2
with NO gas (20 μM) or treating the reduced Miner2 [2Fe–2S] clusters with NO gas under
anaerobic conditions as described previously [7]. Nitric oxide gas (Praxair Co.) was first passed
through a soda-lima column to remove NO2 and higher nitrogen oxides before being used to
bubble pre-degassed water in a sealed 50-ml flask for 5 min. The concentration of nitric oxide in
the NO-saturated solution was measured using a nitric oxide electrode (World Precision
Instrument.) [26]. The UV–visible absorption spectra were recorded in a Beckman DU640 UV–
visible spectrometer equipped with a temperature controller. The extinction coefficient of
11.88 cm−1mM−1 was used to determine the concentration of apo-Miner2.
Chemicals
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NADH, isopropyl-β-d-1-thiogalactopyranoside, and kanamycin were purchased from
Research Product International co. DAF-FM (4-amino-5-methylamino-2′,7′-difluorofluorescein)
was purchased from ThermoFisher Scientific co. The diethylamine NONOate and Griess
Reagent were purchased from Cayman Chemical co. FMN and other chemicals were purchased
from Sigma co. The extinction coefficients of 6.2 mM−1cm−1 at 340 nm and 12.5 mM−1cm−1
at 445 nm were used for determining the concentrations of NADH and FMN, respectively [27].
FMNH2 was prepared by using NADH and E. coli flavin reductase under anaerobic conditions
as described in Ref. [28].
NO analyses
The NO-bound Miner2 [2Fe–2S] clusters were exposed to either room light (600 Lux) or
a Cole-Parmer 41,720 series Illuminator A (400k Lux) which provides strong visible light source
under aerobic or anaerobic conditions. The Cole-Parmer illuminator was equipped with an
infrared filter that reduces the transmittance of heat to the sample. The intensity of the light
excitation was measured using a Digital Lux Meter (LX1330B, Dr. Meter). Anaerobic conditions
were achieved by purging a gas-sealed cuvette with pure Argon gas for 10 min in dark. DAF-FM
(4-amino-5-methylamino-2′,7′-difluorofluorescein) was used to detect NO release. DAF-FM
interacts with NO to form a benzotriazole product which has fluorescence (ThermoFisher
Scientific co). The fluorescence spectra were taken upon excitation at 485 nm in a
spectrofluorometer (FP-6300 Spectrofluorometer, Jasco Co.). The fluorescence intensity was
also measured in a plate reader (Victor3 1420 Multilabel Counter, PerkinElmer Co.) using the
emission wavelength at 535 nm and the excitation wavelength at 485 nm. Similar results were
obtained from the spectrofluorometer and the plate reader. The NO-releasing reagent
diethylamine NONOate (Cayman Chemicals co.) was used as the NO standard solution. A few
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crystals of diethylamine NONOate was first dissolved in buffer containing Tris (20 mM, pH
10.5), and the concentration of the NONOate was determined at 250 nm using an extinction
coefficient of 6.5 mM−1cm−1. The NONOate was then transferred to buffer containing 20 mM
Tris (pH 8.0) and 500 mM NaCl for the NO release under anaerobic conditions. Each NONOate
molecule releases 1.5 equivalents of NO in buffer containing 20 mM Tris (pH 8.0) and 500 mM
NaCl after incubation at 37 °C for 10 min (Cayman Chemicals co.).
EPR measurements
The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a
Bruker model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow
cryostat. Routine EPR conditions: microwave frequency, 9.47 GHz; microwave power,
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 20 K;
receiver gain, 2 × 105.
Mass spectrometry measurements
For the mass spectrometry measurements, the protein samples were dissolved in 20 mM
ammonium acetate (pH 8.0) buffer. The protein samples were either exposed to light excitation
(400k lux) or left in dark at room temperature. Mass spectrometry experiments were carried out
in the LSU mass spectrometry facility. Protein concentration was about 10 μM. All experiments
were performed with an AmaZon speed electron transfer dissociation Ion Trap mass
spectrometer (Bruker Daltonics, Billerica, MA, USA). Sample solution was infused via an
Apollo II electrospray ion source using a syringe pump at the flow rate of 3 μL/min. MS
detection was performed in a full-scan mode in positive ionization enhanced resolution mode
with the scan speed of 8100 m/z/s. The parameter settings for ESI-MS were as follows: capillary
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voltage, 4500 V; end plate offset, −500 V; nebulizer, 8 psi; dry gas, 4 L/min; dry gas
temperature, 100 °C. MS data were acquired from 300 to 3000 with a target mass of 1200 m/z
and trap drive level of 100%. The software used for data processing and de-convolution was
Compass DataAnalysis (Bruker Daltonics, Billerica, MA, USA). The mass spectrometry data
were analyzed using mMass software [29].

3.3 Results
The NO-bound Miner2 [2Fe–2S] clusters are light sensitive
Purified human Miner2 [2Fe–2S] clusters are in an oxidized state which have an
absorption peak at 458 nm. When the Miner2 [2Fe–2S] clusters are reduced, the absorption peak
at 458 nm is shifted to 420 nm [7]. In the previous studies, we have found that the reduced
Miner2 [2Fe–2S] clusters, but not the oxidized ones, are able to bind nitric oxide (NO) and form
the stable NO-bound Miner2 [2Fe–2S] clusters which have a new distinct absorption peak at
422 nm [7].
In the subsequent studies, we have noticed that when the NO-bound Miner2 [2Fe–2S]
clusters were exposed to room light under aerobic conditions, the absorption peak at 422 nm of
the NO-bound Miner2 [2Fe–2S] clusters was gradually shifted to the absorption peak at 458 nm
of the oxidized Mienr2 [2Fe–2S] clusters (Figure. 3.1A). This observation let us to speculate that
the NO-bound Miner2 [2Fe–2S] clusters could be light sensitive. To test the idea, the NO-bound
Miner2 [2Fe–2S] clusters were subjected to a strong light source (400K Lux) which provides
strong visible light under aerobic conditions. Figure. 3.1B shows that after the strong visible light
excitation, the absorption peak at 422 nm of the NO-bound Miner2 [2Fe–2S] clusters was
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quickly changed to the absorption peak at 458 nm of the oxidized Miner2 [2Fe–2S] clusters. The
light excitation for about 30 s was sufficient to fully convert the NO-bound Miner2 [2Fe–2S]
clusters) to the oxidized Miner2 [2Fe–2S] clusters under aerobic conditions (Figure. 3.1C). Thus,
the NO-bound Miner2 [2Fe–2S] clusters are light sensitive, and the NO-bound Miner2 [2Fe–2S]
clusters may be converted to the oxidized Miner2 [2Fe–2S] clusters by the light excitation under
aerobic conditions.

Figure. 3.1 The NO-bound Miner2 [2Fe–2S] clusters are light sensitive.
A), effect of room light on the NO-bound Miner2 [2Fe–2S] clusters. Spectrum 1, the NO-bound
(fig. caption cont'd.)
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Miner2 [2Fe–2S] clusters (10 μM) were incubated under dark for 1 h under aerobic conditions.
Spectrum 2, the NO-bound Miner2 [2Fe–2S] clusters (10 μM) were incubated under room light
for 1 h under aerobic conditions. B), effect of the light excitation on the NO-bound Miner2 [2Fe–
2S] clusters. Spectrum 1, the NO-bound Miner2 [2Fe–2S] clusters (10 μM) were incubated in
dark for 90 s under aerobic conditions. Spectrum 2, the NO-bound Miner2 [2Fe–2S] clusters
(10 μM) were exposed to the strong light excitation (400K Lux) for 90 s under aerobic
conditions. C), transition from the NO-bound Miner2 [2Fe–2S] clusters to the oxidized Miner2
[2Fe–2S] clusters upon the light excitation. The NO-bound Miner2 [2Fe–2S] clusters were
exposed to the strong light excitation (400K Lux) for the indicated time. The absorption spectra
were taken after each light exposure. Absorption peaks at 422 nm and 458 nm represent the NObound Miner2 [2Fe–2S] clusters and the oxidized Miner2 [2Fe–2S] clusters, respectively.

The NO-bound Miner2 [2Fe–2S] clusters release NO upon light excitation
Previous studies have shown that when the NO-bound Miner2 [2Fe–2S] clusters were
treated with Griess Reagent, nitrite was released from the NO-bound clusters due to denaturation
of the protein [7]. Here, we used the Griess Reagent to explore whether the NO was actually
removed from the NO-bound [2Fe–2S] clusters in Miner2 upon the light excitation. In the
experiments, after the NO-bound Miner2 [2Fe–2S] clusters were exposed to the light excitation,
the protein was re-purified by passing through a HiTrap Desalting column (GE Healthcare Life
Sciences). Re-purified protein was then treated with Griess Reagents. As shown in Figure. 3.2A,
the light excitation almost completely eliminated the acid-labile nitrite of the NO-bound [2Fe–
2S] clusters in Miner2. On the other hand, the [2Fe–2S] clusters in Miner2 remained intact after
the light excitation, suggesting that the NO-bound Miner2 [2Fe–2S] clusters only release NO
upon the light excitation.
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Figure. 3.2 NO is released from the NO-bound Miner2 [2Fe–2S] clusters upon light excitation.
A), the NO-bound Miner2 [2Fe–2S] clusters release NO after the light excitation. The Miner2
[2Fe–2S] clusters or the NO-bound Miner2 [2Fe–2S] clusters (10 μM each) were either kept in
dark or subjected to the light excitation (400K Lux) 60 s, followed by re-purification of the
protein by passing through a High-Trap Desalting column. Re-purified proteins were then
incubated with Griess Regents to determine the acid-labile nitrite. Sodium nitrite solution
(1 mM) was used as a standard. Data were averages ± standard deviation from three experiments.
B), mass spectra of the NO-bound Miner2 [2Fe–2S] clusters before and after the light excitation
(400K Lux for 60 s). Spectrum 1, the NO-bound Miner2 [2Fe–2S] clusters. Spectrum 2, same as
in spectrum 1 except after the light excitation. The mass spectra were deconvoluted using mMass
software [29]. C), fluorescence spectra of DAF-FM incubated with the Miner2 [2Fe–2S] clusters
under dark (spectrum 1) or after the light excitation (spectrum 2). The Miner2 [2Fe–2S] clusters
(10 μM) were incubated with DAF-FM (4-amino-5-methylamino-2′,7′-difluorofluorescein)
(10 μM) in dark for 2 min at room temperature under aerobic conditions. The samples were either
(fig. caption cont'd.)
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kept in dark or exposed to the light excitation (400K Lux) for 60 s. The fluorescence spectra
were taken using the excitation wavelength at 485 nm. D), fluorescence spectra of DAF-FM
incubated with the NO-bound Miner2 [2Fe–2S] clusters under dark (spectrum 1) or after the light
excitation (spectrum 2). Same as in C), except the NO-bound Miner2 [2Fe–2S] clusters (10 μM)
were used.
The NO-bound Miner2 [2Fe–2S] clusters were also subjected to the Electrospray
Ionization (ESI) mass spectrometry analyses before and after the light excitation. As shown in
Figure. 3.2B, the NO-bound Miner2 [2Fe–2S] clusters had a major mass peak at 12,889 before
the light excitation. After the light excitation, the mass peak at 12,889 disappeared and was
replaced with a new mass peak at 12,827, a mass decrease of 62 Da. The same mass peak at
12,827 was observed in the purified Miner2 [2Fe–2S] clusters which represents the sum of the
Miner2 peptide (12,784) with a likely N-terminal acetylation (43) [30] and two [2Fe–2S] clusters
(2 × 176). As each Miner2 protein hosts two [2Fe–2S] clusters and each [2Fe–2S] cluster can
bind one NO [7], release of two NO molecules from the NO-bound Miner2 [2Fe–2S] clusters by
the light excitation would result in the mass decrease by 62 Da. Thus, the mass spectrometry
results suggested that the NO-bound Miner2 [2Fe–2S] clusters release two NO molecules upon
the light excitation.
To further explore whether NO gas was released from the NO-bound Miner2 [2Fe–2S]
clusters by the light excitation, we used the NO probe DAF-FM (4-amino-5-methylamino-2′,7′difluorofluorescein) [31]. DAF-FM is essentially nonfluorescent until it reacts with NO to form a
fluorescent benzotriazole (Thermo Fisher Scientific co). In the experiments, the Miner2 [2Fe–
2S] clusters or the NO-bound Miner2 [2Fe–2S] clusters were incubated with DAF-FM under
aerobic conditions, followed by the light excitation (400K Lux for 90 s). Figure. 3.2C shows that
when the Miner2 [2Fe–2S] clusters were exposed to the light excitation, very little change of the
fluorescence intensity of DAF-FM was observed. On the other hand, when the NO-bound
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Miner2 [2Fe–2S] clusters mixed with DAF-FM were exposed to the light excitation, the
fluorescence intensity of DAF-FM was significantly increased (Figure. 3.2D). Using the
diethylamine NONOate as the NO standard solution, we estimated that about 3.4 ± 0.2 μM NO
was released from 10 μM of the NO-bound Miner2 [2Fe–2S] clusters after the light excitation.

The NO-bound Miner2 [2Fe–2S] clusters are converted to the reduced Miner2 [2Fe–2S]
clusters by the light excitation under anaerobic conditions

To determine whether oxygen is required for the light-induced NO release from the NObound Miner2 [2Fe–2S] clusters, we measured the UV–visible absorption spectrum of the NObound Miner2 [2Fe–2S] clusters before and after the light excitation under anaerobic conditions.
Figure. 3.3A shows that after the light excitation, the absorption peak at 422 nm of the NObound Miner2 [2Fe–2S] clusters was shifted to the peak at 420 nm. Because the absorption peak
at 420 nm reflects the reduced Miner2 [2Fe–2S] clusters [7], the results suggested that the NObound Miner2 [2Fe–2S] clusters are converted to the reduced Miner2 [2Fe–2S] clusters by the
light excitation under anaerobic conditions.
In previous studies, we have shown that the reduced Miner2 [2Fe–2S] clusters have a
distinct Electron Paramagnetic Resonance (EPR) signal at g = 1.92, and the NO-bound Miner2
[2Fe–2S] clusters are EPR-silent [7]. Here, we used EPR to examine whether the reduced Miner2
[2Fe–2S] clusters are actually formed when the NO-bound Miner2 [2Fe–2S] clusters are exposed
to the light excitation under anaerobic conditions. Figure. 3.3B shows that the NO-bound Miner2
[2F–2S] clusters had an EPR signal at g = 2.04 which represented a small amount of dinitrosyl
iron complex formed during the NO treatment of Miner2 [7]. When the NO-bound Miner2 [2Fe–
2S] clusters were exposed to the light excitation under anaerobic conditions, a new EPR signal at
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g = 1.92 of the reduced Miner2 [2Fe–2S] clusters appeared (Figure. 3.3B). Integration of the EPR
signal at g = 1.92 revealed that about 6.2 ± 0.5 μM of the reduced Miner2 [2Fe–2S] clusters were
formed after 10 μM of the NO-bound Miner2 [2Fe–2S] clusters were exposed to the light
excitation under anaerobic conditions. It should be pointed out that the EPR signal at g = 2.04 of
the dinitrosyl iron complex was not changed upon the light excitation (Figure. 3.3B), indicating
that dinitrosyl iron complex was not light sensitive. Taken together, the results established that
the NO-bound Miner2 [2Fe–2S] clusters are converted to the reduced Miner2 [2Fe–2S] clusters
by the light excitation under anaerobic conditions.

Figure. 3.3 Oxygen is not required for the light-induced NO release from the NO-bound Miner2
[2Fe–2S] clusters.
A), UV–visible absorption spectra of the NO-bound Miner2 [2Fe–2S] clusters before and after
the light excitation under anaerobic conditions. The NO-bound Miner2 [2Fe–2S] clusters
(10 μM) were incubated under anaerobic conditions, followed by exposure to the light excitation
(400K Lux) for 0, 5, 10, 15, and 20 s. Spectra were taken after each light excitation. B), EPR
spectra of the NO-bound Miner2 [2Fe–2S] clusters. Spectrum 1, the NO-bound Miner2 [2Fe–2S]
clusters (10 μM). Spectrum 2, same as in spectrum 1 except after the light excitation (400K Lux
for 60 s) under anaerobic conditions. The results are representatives from three independent
experiments.
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NO binding inhibits the redox transition of the Miner2 [2Fe–2S] clusters
Like the mitoNEET [2Fe–2S] clusters [28], the Miner2 [2Fe–2S] clusters can be reduced
by the reduced flavin mononucleotide (FMNH2) and oxidized by oxygen. Figure. 3.4A shows
that the oxidized Miner2 [2Fe–2S] clusters were readily reduced by FMNH2 under anaerobic
conditions, and that the reduced Miner2 [2Fe–2S] clusters were re-oxidized after exposure to air,
indicating that the Miner2 [2Fe–2S] clusters can undergo redox transition. In contrast, the NObound Miner2 [2Fe–2S] clusters could not be reduced by FMNH2 or oxidized by oxygen, as the
absorption peak at 422 nm of the NO-bound Miner2 [2Fe–2S] clusters remained the same upon
addition of FMNH2 or exposure to air (Figure. 3.4B). The results suggested that the NO-bound
Miner2 [2Fe–2S] clusters are resistant to redox transition. When the NO-bound Miner2 [2Fe–2S]
clusters were exposed to the light excitation, the NO-bound Miner2 [2Fe–2S] clusters quickly
became the reduced Miner2 [2Fe–2S] clusters under anaerobic conditions, and further exposure
to air led to oxidation of the reduced Miner2 [2Fe–2S] clusters (Figure. 3.4C). The results
suggested that release of NO from the NO-bound Miner2 [2Fe–2S] clusters restores the redox
transition activity of the Miner2 [2Fe–2S] clusters.
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Figure. 3.4 NO inhibits the redox transition of the Miner2 [2Fe–2S] clusters.
A), reduction and oxidation of the Miner2 [2Fe–2S] clusters. Purified Miner2 (10 μM) (spectrum
1) was incubated with FMN (0.1 μM), NADH (20 μM) and E. coli flavin reductase (0.1 μM) for
5 min under anaerobic conditions (spectrum 2). The sample was then exposed to air for 10 min
(spectrum 3). B), effect of oxygen and FMNH2 on the NO-bound Miner2 [2Fe–2S] clusters. The
NO-bound Miner2 [2Fe–2S] clusters (10 μM) (spectrum 1) was incubated with FMN (0.1 μM),
NADH (20 μM) and E. coli flavin reductase (0.1 μM) for 5 min under anaerobic conditions
(spectrum 2). The sample was then exposed to air for 10 min (spectrum 3). C), oxidation of the
NO-bound Miner2 [2Fe–2S] clusters by the light excitation and air. The NO-bound Miner2
[2Fe–2S] clusters (10 μM) (spectrum 1) were exposed to the light excitation (400K Lux) for 30 s
under anaerobic conditions (spectrum 2), followed by exposure to air for 10 min (spectrum 3).
Absorption peaks at 422 nm, 420 nm, and 458 nm represent the NO-bound Miner2 [2Fe–2S]
clusters, the reduced Miner2 [2Fe–2S] clusters, and the oxidized Miner2 [2Fe–2S] clusters,
respectively.
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3.4 Discussion
In previous studies, we have shown that the mitochondrial matrix protein Miner2 [2Fe–
2S] clusters have a unique activity to bind NO and form the stable NO-bound [2Fe–2S] clusters
[7]. Here, we report that the NO-bound [2Fe–2S] clusters in Miner2 are light sensitive. Upon the
light excitation, the NO-bound Miner2 [2Fe–2S] clusters release NO and become the reduced
Miner2 [2Fe–2S] clusters under anaerobic conditions. Additional studies further reveal that
binding of NO effectively inhibits the redox transition of the Miner2 [2Fe–2S] clusters,
indicating that NO may modulate the physiological function of Miner2 in mitochondria by
directly binding to the CDGSH-type [2Fe–2S] clusters.
NO has a high reactivity with heme and iron-sulfur clusters in proteins [32,33]. The
binding of NO to heme has been extensively investigated in proteins such as soluble guanylate
cyclase [34]. However, much less has been known about the specific interactions between NO
and iron-sulfur clusters in proteins. Previous studies from different research groups including
ours have shown that iron-sulfur clusters in proteins are readily disrupted by NO, forming the
dinitrosyl iron complex [18,21,22], the thiolate-bridged diiron tetranitrosyl complex [23], or the
octa-nitrosyl cluster [24]. To the best of our knowledge, the Miner2 CDGSH-type [2Fe–2S]
clusters represent the first example that the [2Fe–2S] clusters can bind NO and form stable NObound clusters [7]. The unique NO binding activity of the CDGSH-type [2Fe–2S] cluster in
Miner2 is likely due to its unusual ligand arrangement of three cysteine and one histidine
residues [8]. In the CDGSH-type [2Fe–2S] clusters, one of the iron atoms is ligated via two
cysteine residues and the other iron via one cysteine and one histidine residues [8]. The iron
center ligated via cysteine/histidine residues in the [2Fe–2S] cluster is most likely redox active
[35]. In this context, we propose that NO binds to the ferrous iron in the reduced Miner2 [2Fe–
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2S] cluster (Figure. 3.5), which is reminiscent of the NO binding in the ferrous heme in proteins
[34]. The NO binding affinity for the ferrous heme in proteins is extremely high with the binding
constant of about 1011 M−1 [36]. On the other hand, the NO binding affinity for the ferric heme
in proteins is relatively weaker with the binding constant in the range of 103 to 105 M−1 [37].
Accordingly, we find that the oxidized Miner2 [2Fe–2S] clusters fail to bind NO, and only the
reduced Miner2 [2Fe–2S] clusters are able to bind NO with a high binding affinity [7]. Since the
redox midpoint potent (Em) of the CDGSH-type [2Fe–2S] clusters in mitoNEET is about
0 mV at pH 7.0 [38], it is most likely that the [2Fe–2S] clusters in Miner2 are in a reduced state
in mitochondria [7]. Thus, the Miner2 [2Fe–2S] clusters are capable of binding NO under
physiological conditions.

Figure. 3.5 Proposed model for the NO-mediated inhibition of the redox transition of the Miner2
[2Fe–2S] clusters. Mitochondrial protein Miner2 contains two [2Fe–2S] clusters. Only one of the
[2Fe–2S] clusters is shown. In the reduced Miner2 [2Fe–2S] cluster, the iron atom ligated with
his/cys is in ferrous state and can be oxidized by oxygen. When NO binds to the ferrous iron
atom in the reduced [2Fe–2S] cluster, the cluster can no longer be oxidized by oxygen or reduced
by FMNH2. When NO is released from ten NO-bound Miner2 [2Fe–2S] clusters by light
excitation, the oxidation of the reduced Miner [2Fe–2S] clusters by oxygen is restored.
While the NO-bound Miner2 [2Fe–2S] clusters are stable under aerobic or anaerobic
conditions, they are highly sensitive to visible light (Figure. 3.1). The mass spectrometry
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analyses showed that two NO molecules may be released from the NO-bound Miner2 [2Fe–2S]
clusters by the light excitation (Figure. 3.2B). The EPR and UV–visible absorption
measurements further revealed that the NO-bound Miner2 [2Fe–2S] clusters are converted to the
reduced Miner2 [2Fe–2S] clusters upon the light excitation under anaerobic conditions (Figure.
3.3), demonstrating that the NO binding in the reduced Miner2 [2Fe–2S] clusters is reversible.
We were unable to observe the re-binding of NO to the reduced Miner2 [2Fe–2S] clusters after
the light excitation, likely due to the diffusion of NO and/or the reaction of NO with other
reactants in the solution. However, addition of extra NO to the reaction solution resulted in rebinding of NO to the reduced Miner2 [2Fe–2S] clusters in dark (data not shown), further
supporting a notion that the reduced Miner2 [2Fe–2S] clusters can reversibly bind NO.
Like the mitoNEET [2Fe–2S] clusters, the Miner2 [2Fe–2S] clusters can be readily
reduced by FMNH2 and oxidized by oxygen. However, the NO-bound Miner2 [2Fe–2S] clusters
are resistant to reduction or oxidation (Figure. 3.4B). When NO is released from the NO-bound
Miner2 [2Fe–2S] clusters by the light excitation, the reduced Miner2 [2Fe–2S] clusters can be
re-oxidized by oxygen (Figure. 3.4C), suggesting that NO binding effectively blocks the redox
transition of the Miner2 [2Fe–2S] clusters (Figure. 3.5). It has been reported that the
mononuclear iron center in nitrile hydratase from Rhodococcus sp. N-771 has a strong binding
activity for NO [39]. Purified nitrile hydratase is inactive due to NO binding in the mononuclear
iron center, and light excitation releases NO from nitrile hydratase and activates the enzyme
activity [40]. For the NO-bound Miner2 [2Fe–2S] clusters, release of NO by light excitation
appears to also restore the redox transition of the Miner2 [2Fe–2S] clusters. While the
mechanism by which the light-induced release of NO from the NO-bound Miner2 [2Fe–2S]
clusters is not fully understood, our results strongly suggested that the NO binding in the reduced
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Miner2 [2Fe–2S] clusters is reversible, and NO may change the physiological activity of Miner2
in mitochondria by directly binding to the [2Fe–2S] clusters. Since there are many CDGSH-type
[2Fe–2S] proteins found in human cells [4], the reversible NO binding in the Miner2 [2Fe–2S]
clusters may represent a novel example of NO regulation via the CDGSH-type [2Fe–2S] clusters
in proteins.
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CHAPTER 4. CONCLUSIONS
Human mitoNEET has a key role in iron homeostasis, production of reactive oxygen
species and energy metabolism in mitochondria. Here we find that mitoNEET is a novel electron
transfer protein that can catalyzes the electron transfer from NADH to oxygen or ubiquinone. We
also identify a unique binding site of flavin mononucleotide (FMN) binding site in mitoNEET,
which is different from but overlaps with the binding sites of type II diabetes drug Pioglitazone
in mitoNEET. Pioglitazone or its homologs can effectively inhibit the electron transfer activity
of mitoNEET, apparently by competing with FMN binding in mitoNEET. We propose that
mitoNEET may promote glycolysis in cytosol by oxidizing cytosolic NADH and regulate energy
metabolism in normal and cancer cells. We also find that the human Miner2 [2Fe-2S] clusters
can reversibly bind nitric oxide without disruption of the clusters. Binding of nitric oxide to the
[2Fe-2S] clusters in Miner2 effectively inhibit the electron transfer activity of Miner2,
demonstrating that nitric oxide may regulate energy metabolism by directly binding to the [2Fe2S] clusters in the NEET-proteins in mitochondria.
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